News New Huntington’s drug granted priority designation Roche’s treatment for Huntington’s disease has received a priority designation by the European regulator, sparking hope that a cure may be in the pipeline.
News Roche takes on development of potential Huntington’s breakth... Ionis has completed its licensing agreement with Roche for IONIS-HTTRx, a drug which could be a breakthrough in treating Huntington’s disease.
News Huntington's Disease wearable gets backing from NIH BioSensics' HDWear provides real-time motor function scores in Huntington's patients.
News FDA approves Teva's Huntington's Disease drug First treatment approved for Huntington's Disease in almost a decade.
News Teva files orphan blockbuster hope in tardive dyskinesia SD-809 will be vital for Teva if approved.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.